20, 25-DIAZACHOLESTENOL DIHYDROCHLORIDE. INHIBITION OF CHOLESTEROL BIOSYNTHESIS IN HYPERLIPEMIC SUBJECTS.
D015068:17-Ketosteroids; D000924:Anticholesteremic Agents; D000963:Antimetabolites; D002784:Cholesterol / Q000097:blood*; D002845:Chromatography; D004358:Drug Therapy; D005826:Genetics, Medical; D005989:Glycerides; D006937:Hypercholesterolemia; D006949:Hyperlipidemias; D050356:Lipid Metabolism; D008052:Lipid Metabolism, Inborn Errors; D008055:Lipids / Q000097:blood*; D008074:Lipoproteins; D008111:Liver Function Tests; D009404:Nephrotic Syndrome; D010743:Phospholipids; D013261:Sterols; D014116:Toxicology; D014308:Triparanol; D014556:Urine; D014974:Xanthomonas
D015068:17-Ketosteroids; D000924:Anticholesteremic Agents; D000963:Antimetabolites; D005989:Glycerides; D008055:Lipids; D008074:Lipoproteins; D010743:Phospholipids; D013261:Sterols; D014308:Triparanol; D002784:Cholesterol
17-KETOSTEROIDS; ANTICHOLESTEREMIC AGENTS; ANTIMETABOLITES; BLOOD CHOLESTEROL; BLOOD LIPIDS; CHROMATOGRAPHY; DRUG THERAPY; GENETICS, HUMAN; GLYCERIDES; HYPERCHOLESTEREMIA; HYPERLIPEMIA; LIPID METABOLISM, INBORN ERRORS; LIPOPROTEINS; LIVER FUNCTION TESTS; NEPHROTIC SYNDROME; PHOSPHOLIPIDS; STEROLS; TOXICOLOGIC REPORT; TRIPARANOL; URINE; XANTHOMONAS